Competitive Positioning Strategies for South Korean Biotech Companies

Competitive Positioning Strategies for South Korean Biotech Companies

 

RELEASE DATE
06-Nov-2003
REGION
Asia Pacific
Research Code: 4097-01-00-00-00
SKU: HC00082-AP-MR_02810
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00082-AP-MR_02810
$1,500.00
DownloadLink
ENQUIRE NOW

Description

South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech startups, pharmaceutical companies and chaebols have invested in biotech research. The South Korean investment community still considers the biotech investments to be risky propositions and prefer short term capital returns. However, increasing aging population and demand for newer products have created new opportunities for biotech companies in South Korea.

Table of Contents

Introduction

  • Introduction

Market Overview and Opportunity Analysis

  • Market Overview
  • Opportunity Analysis

Introduction

Market Drivers

  • Introduction
  • Key Biotech Markets

Biotech Market in Asia Pacific

  • Market Drivers
  • Protection of Intellectual Property Rights
  • Low Cost R&D Base
  • Availability of Public Domain Knowledge Base

SWOT Analysis of South Korea as a Biotech Hub

Attractiveness of South Korea as a Biotech Destination for International Players

Current Competitive Position of South Korea

Strategies for Achieving Competitive Success

South Korea's Future Position as a Biotechnology Hub

South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech startups, pharmaceutical companies and chaebols have invested in biotech research. The South Korean investment community still considers the biotech investments to be risky propositions and prefer short term capital returns. However, increasing aging population and demand for newer products have created new opportunities for biotech companies in South Korea.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 4097-01-00-00-00
Is Prebook No